Patents by Inventor Naresh Kumar

Naresh Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-SUBSTITUTED ISOFLAVONOID COMPOUNDS AND USES THEREOF
    Publication number: 20120003270
    Abstract: The present invention relates to 6-substituted isoflavonoid compounds and compositions comprising same. The invention further relates to the use of 6-substituted isoflavonoid compounds for the treatment of various diseases and conditions.
    Type: Application
    Filed: July 30, 2009
    Publication date: January 5, 2012
    Inventors: Alan James Husband, Michael James, Naresh Kumar
  • SYSTEM AND METHOD FOR BILLING SYSTEM INTERFACE FAILOVER RESOLUTION
    Publication number: 20110283003
    Abstract: A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty.
    Type: Application
    Filed: July 24, 2011
    Publication date: November 17, 2011
    Inventors: Naresh Kumar, Robert Perry
  • System and method for billing system interface failover resolution
    Patent number: 8010594
    Abstract: A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: August 30, 2011
    Assignee: Time Warner Cable Inc.
    Inventors: Naresh Kumar, Robert Perry
  • PROCESS FOR PREPARING A CARBAPENEM ANTIBIOTIC COMPOSITION
    Publication number: 20110172201
    Abstract: The present invention relates to a process for preparing a carbapenem antibiotic composition. The present invention further relates to a carbapenem antibiotic composition substantially free of degradation impurities. The present invention further relates to a polymorphic form of ertapenem mono sodium designated as Form D and its preparation.
    Type: Application
    Filed: June 12, 2009
    Publication date: July 14, 2011
    Applicant: Ranbaxy Laboratories Limited
    Inventors: Vinod George, Bhupendra Vashishta, Mohan Prasad, Naresh Kumar, Vinod Kumar Arora
  • BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS
    Publication number: 20110166088
    Abstract: The present invention provides Gyrase B and/or Topoisomerase IV par E inhibitors, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonas spp., Acenetobacter spp., Moraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Ktycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Corynebacterium, Bacillus spp., Enterobactericeae,’ (E. coli, Klebsiella spp., Proteus spp., etc.) or any combination thereof. Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections.
    Type: Application
    Filed: June 25, 2009
    Publication date: July 7, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jitendra A. Sattigeri, Naresh Kumar, Ajay Yadav, Lalima Sharma, Ian A. Cliffe, Shibu B. Varughese, Shaikh Rizwan Shabbir, V. Samuel Raj, Dilip J. Upadhyay, Pradip K. Bhatnager
  • Dynamic conditional security policy extensions
    Patent number: 7945960
    Abstract: Systems, methods, and machine-readable media are disclosed for providing conditional grants of permission in an externally configured security policy. In one embodiment, a method is provided which comprises reading a condition clause from a grant statement defined in the security policy. The grant statement can cause the granting of permission for a user to access a requested resource. One or more constraints on the grant statement can be determined based on the condition clause. Permission can be granted to access the requested resource based on the one or more constraints.
    Type: Grant
    Filed: December 6, 2005
    Date of Patent: May 17, 2011
    Assignee: Oracle International Corporation
    Inventors: Raymond K. Ng, Ganesh Kirti, Thomas Keefe, Naresh Kumar
  • Production of isoflavone derivatives
    Patent number: 7906660
    Abstract: Methods for the hydrogenation of isoflavones are described which provide access to workable quantities of isoflavan-4-ols, isoflav-3-enes, and isoflavans. The isoflavone derivatives can be obtained in high purity and in near quantitative yields whilst employing pharmaceutically acceptable reagents and solvents.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: March 15, 2011
    Assignee: Novogen Research Pty Ltd
    Inventors: Andrew Heaton, Naresh Kumar
  • OXAZINYL ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USE
    Publication number: 20110046722
    Abstract: The invention provides oxazinyl isoflavonoid compounds and compositions containing same, methods for their preparation and their use as therapeutic agents particularly as cardioprotective, anti-inflammatory, anti-oxidant and chemotherapeutic agents.
    Type: Application
    Filed: February 29, 2008
    Publication date: February 24, 2011
    Inventors: Andrew Heaton, Naresh Kumar, Catherine Walker
  • Methods and apparatus for analyzing and management of application traffic on networks
    Patent number: 7804787
    Abstract: An apparatus and method are provided for analyzing traffic on a network by monitoring packets sent between devices on the network and identifying applications occurring between devices on the network based on information derived from monitoring the packets. Techniques are provided to examine header information of the packets, such as information in the header of Internet Protocol (IP) packets, to identify applications that are occurring on the network. In some cases, information about the packet beyond the header information is examined to match a packet to a particular application. Using these techniques, a list is built of all of the applications occurring between devices on the network. Parameters may be generated to track one or more of the response time, latency and traffic volume associated with a particular device on the network.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: September 28, 2010
    Assignee: Fluke Corporation
    Inventors: Gordon Brandyburg, Naresh Kumar Kannan, Jeff Kobryn, Kent Laver, James Thomas Menzies, Thomas R. Nisbet, Matthew A. Tucker
  • Synergistic hepatoprotective composition and a method thereof
    Patent number: 7794753
    Abstract: The present invention relates to a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) in the ratio ranging between 1:7 to 7:1 (w/w), useful in hepatoprotection; and a process for the preparation of a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) useful in hepatoprotection, said process comprising steps of grounding the particles of the t-TCA and AP into fine particles, mixing the fine particles in ratio ranging between 1:7 to 7:1 (w/w), and grinding the mixture to obtain formulation, and also, a method of hepatoprotection of a subject using the synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP), said method comprising the steps of administering the formulation to the subject.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: September 14, 2010
    Assignee: Council of Scientific and Industrial Research
    Inventors: Vishwa Nath Gupta, Krishan Avtar Suri, Bishan Datt Gupta, Bupinder Singh Jaggi, Naresh Kumar Satti, Bal Krishan Chandan, Neelam Sharma, Vikram Bhardwaj, Om Parkash Suri, Ghulam Nabi Qazi, Jyotsna Suri, Madalsa Bargotra
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100222393
    Abstract: Compounds of Formula (I), wherein represents a single bond when G is —OH and double bond when G is —O; R1 and R2 are independently selected from hydrogen, alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl or heteroarylalkyl; R3 is selected from the group selected from hydrogen, hydroxy, alkoxy, alkenyloxy or alkynyloxy; X is selected from oxygen, —NH, —NR (wherein R is alkyl, alkenyl, alkenyl, alkynyl or aryl), sulphur or no atom; Het is heterocyclyl or heteroaryl; n is an integer from 1 to 6; are muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and 4 i gastrointestinal systems mediated through muscarinic receptors.
    Type: Application
    Filed: December 21, 2006
    Publication date: September 2, 2010
    Inventors: Naresh Kumar, Jaskiran Kaur, Venkata P. Palle, Beenu Bhatt, Shelly Jindal, Anita Chugh, Suman Gupta, Abhijit Ray, Shivani Malhotra, Raj Kumar Shirumalla
  • Methodology for bias temperature instability test
    Patent number: 7759962
    Abstract: A method for performing a bias temperature instability test on a device includes performing a first stress on the device. After the first stress, a first measurement is performed to determine a first parameter of the device. After the first measurement, a second stress is performed on the device, wherein only the first parameter is measured between the first stress and the second stress. The method further includes performing a second measurement to determine a second parameter of the device after the second stress. The second parameter is different from the first parameter.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: July 20, 2010
    Assignee: Taiwan Semiconductor Manufacturing Company, Ltd.
    Inventors: Jiaw-Ren Shih, Neeraj Kumar Jha, Rakesh Ranjan, Naresh Kumar Emani
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100168197
    Abstract: This present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: February 27, 2008
    Publication date: July 1, 2010
    Inventors: Naresh Kumar, Jaskiran Kaur, Shelly Aeron, Abhijit Ray, Suman Gupta, Shivani Malhotra, Raj Kumar Shirumalla
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100144801
    Abstract: The present invention generally relates to muscarinic receptor antagonists of formula I, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors. Formula (I) wherein Het: is heterocyclyl or heteroaryl X: O, S or NR1 and the other substituents are defined as in the claims.
    Type: Application
    Filed: October 2, 2007
    Publication date: June 10, 2010
    Inventors: Naresh Kumar, Jaskiran Kaur, Abhijit Ray, Suman Gupta, Shivani Malhotra, Rajkumar Shirumalla
  • SYNERGISTIC HERBAL OPHTHALMIC FORMULATION FOR LOWERING THE INTRA OCULAR PRESSURE IN CASE OF GLAUCOMA
    Publication number: 20100112106
    Abstract: The present invention relates to a synergistic herbal composition for lowering the intra ocular pressure in different types of glaucoma and process for the preparation of the same in pharmaceutically acceptable dosage forms.
    Type: Application
    Filed: February 27, 2008
    Publication date: May 6, 2010
    Applicant: DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH (DIPSAR)
    Inventors: Suresh Kumar Gupta, Sunder Agrawal, Renu Agrawal, Sushma Srivastava, Ankita Nagpal, Naresh Kumar, Rohit Saxena, Sateesh Kumar, Deepak Bahri
  • Methodology for Bias Temperature Instability Test
    Publication number: 20100097091
    Abstract: A method for performing a bias temperature instability test on a device includes performing a first stress on the device. After the first stress, a first measurement is performed to determine a first parameter of the device. After the first measurement, a second stress is performed on the device, wherein only the first parameter is measured between the first stress and the second stress. The method further includes performing a second measurement to determine a second parameter of the device after the second stress. The second parameter is different from the first parameter.
    Type: Application
    Filed: October 16, 2008
    Publication date: April 22, 2010
    Inventors: Jiaw-Ren Shih, Neeraj Kumar Jha, Rakesh Ranjan, Naresh Kumar Emani
  • Isoflavonoid dimers
    Patent number: 7700644
    Abstract: Novel compounds based on phenyl-substituted naphtho[1,2-g]chrysene compounds (A) are described. The compounds are obtainable by dimerisation of 3-phenylchroman (isoflavonoid) ring systems (B). Methods of synthesis of the novel dimeric compounds, compositions containing same and use of the dimers as therapeutic agents are also described.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: April 20, 2010
    Assignee: Novogen Research Pty Ltd
    Inventors: Andrew Heaton, Naresh Kumar
  • MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100056496
    Abstract: The present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The present invention also relates to processes for preparing compounds described herein, pharmaceutical compositions thereof, and methods for treating diseases mediated through muscarinic receptors. Formula (I) or a pharmaceutically accepted salt, pharmaceutically acceptable solvate, enantiomers, diastereomer, polymorph or N-oxide thereof, wherein X is.
    Type: Application
    Filed: September 4, 2007
    Publication date: March 4, 2010
    Inventors: Naresh Kumar, Kirandeep Kaur, Yogesh D. Shejul, Abhijit Ray, Suman Gupta, Shivani Malhotra, Rajkumar Shirumalla
  • ACID ADDITION SALTS OF MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100035954
    Abstract: Provided herein are acid addition salts of muscarinic receptor antagonists. Such acid addition salts are muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Also provided herein are processes for the preparation of acid addition salts, pharmaceutical compositions thereof, and methods of treating diseases mediated through muscarinic receptors.
    Type: Application
    Filed: December 15, 2004
    Publication date: February 11, 2010
    Inventors: Mohammad Salman, Naresh Kumar
  • Furanone compounds and lactam analogues thereof
    Publication number: 20100035948
    Abstract: The present invention provides a compound of formula I and a compound of formula II, methods of use and formulations thereof.
    Type: Application
    Filed: October 8, 2007
    Publication date: February 11, 2010
    Inventors: Naresh Kumar, George Iskander